Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001187756 | SCV001354627 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001416521 | SCV001618703 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2019-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001187756 | SCV002658569 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003396796 | SCV004121838 | likely benign | not specified | 2023-10-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008732 | SCV004822444 | likely benign | Marfan syndrome | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004546613 | SCV005041348 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | FBN1: BP4, BP7 |